RSS

Medicines

The government has signed up to £86.6 million worth of freight capacity contracts to help ensure medicines can enter the UK after Brexit. Read more

News

The UK will be leaving the EU on 31 October. This will bring important changes to doing business. Here are five things life science companies can do now to get ready. Read more

News

The government has published documentation outlining preparations for a no deal Brexit, which includes how it could affect the supply chain for medicines and medical products. Read more

News

The MHRA has reiterated guidance that it has previously given regarding the regulations of medicines if the UK leaves the European Union without a deal. Read more

News

A smart monitoring solution has been launched to help NHS hospitals improve patient safety through more precise temperature control for medicines. Read more

News

Scientists have developed an innovative test that could help to develop easy to swallow medicines for children and older people. Read more

News

As part of its ‘no deal’ Brexit plans, the Department of Health (DoH) has signed two contracts to store drugs in warehouses, queries by The Guardian have revealed. Read more

News

The UK government will fly vital medical supplies in from Europe during a no-deal Brexit via a dedicated NHS aeroplane, it has been revealed. Read more

News

A new law adopted on Wednesday aims to avoid duplicating national assessments to determine a treatment’s added value that help EU countries decide on pricing. Read more

News

In preparations for Brexit, the EMA has redistributed the UK’s product portfolio to other EU members and is not allocating any centralised marketing authorisation applications to the MHRA. We take a closer look… Read more

Opinion

Here, Dr Sheuli Porkess, deputy chief scientific officer, Association of the British Pharmaceutical Industry (ABPI), outlines how the pharmaceutical industry takes a substance from molecule to medicine and how the process requires persistence. Read more

Opinion

Vetter, has launched its Open Innovation Challenge campaign, aimed at developing innovative, future-focused and sustainable solutions for the injection of medicines that are better streamlined to user needs than current methods. Read more

News

A new study from the University of Eastern Finland, published in the European Journal of Clinical Pharmacology, has highlighted that there are differences in the availability of orphan medicines between different European countries. Read more

Analysis

NHS England has revealed that thousands of patients have benefited from the new CDF and as a result of discounts it has secured on eight treatments, savings of around £140 million should be generated over the course of the next five years Read more

News

The University of Liverpool’s Department of Molecular and Clinical Pharmacology has been awarded a Queen’s Anniversary Prize to recognise its work in the improvement of the safety and effectiveness of medicines. Read more

News

Research from the University of Warwick, evaluating how law can be employed to improve global access to essential medicines, has been published. Read more

News

The Healthcare Distribution Association (HDA UK) has raised concerns about the security of the supply of medicines in the UK following Brexit in response to the Health Select Committee’s inquiry. Read more

News

ABPI responds positively to a letter in the Financial Times from health secretary, Jeremy Hunt, and business secretary, Greg Clark, which lays out plans for the regulation of medicines in the UK after the country leaves the European Union. Read more

News

During the FIP 6th Pharmaceutical Sciences World Congress (PSWC) global representatives from across various pharmaceutical sectors discussed a plan for the discovery and development of new medicines based on systems biology Read more

News

During its March 2017 meeting, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended six medicines for approval, including three orphans. Read more

News